EPCAM and hepatocellular carcinoma: As a result, without optimized protocols, cytokeratin-based detection remains underutilized in flow cytometry workflows, despite its potential to improve CTC identification – particularly in HCC, where surface marker expression such as EpCAM may be variable or lost.